Kings Global Biotech Limited - Company Profile

It is a pharma public limited company based in Pune, Maharashtra, India, established in 2016.
2016 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Kings Global Biotech Limited

Kings Global Biotech Limited, a active public limited company, was established on 09 June 2016 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33119PN2016PLC164905. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.81 Cr.

Formerly known as Kings Global Biotech Limited, Kingsglobal Biotech Limited. It upholds a compliant status. Its leadership includes Kartiki Ramesh Tupe (Additional Director), Manodnya Shashank Sapre (Whole-Time Director), Girish Bhimrao Jaiwal (Director). Past directors included Manodnya Shashank Sapre, Gangubai Bhimrao Jaiwal, Vaibhav Vilas Nagarkar. It holds ₹14.53 Cr open charges and ₹4.81 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mittal Chambers, J.M.Road, Shivajinagar, Pune, Maharashtra, 411030.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33119PN2016PLC164905

  • Registration Number

    164905

  • Incorporation Date

    09 June 2016

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.81 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.81 Cr
  • Company Age 9 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 14.53 Cr
  • Satisfied Charges ₹ 4.81 Cr
  • Revenue Growth **** 38.73%
  • Profit Growth **** 10.09%
  • Ebitda **** 24.41%
  • Net Worth 15.99%
  • Total Assets **** 143.71%
Company report

Kings Global Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kings Global Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kings Global Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Kartiki Ramesh Tupe Additional Director 28 Sep 2022 Current
Manodnya Shashank Sapre Whole-Time Director 14 Mar 2020 Current
Girish Bhimrao Jaiwal Director 09 Jun 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2020 Past
Pramod Abcsdd Director 18 Jun 2019 Past
Pramod Abcsdd Additional Director 14 Mar 2020 Past
Pramod Abcsdd Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kings Global Biotech.

Kings Global Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.73% increase. The company also saw a substantial improvement in profitability, with a 10.09% increase in profit. The company's net worth Soared by an impressive increase of 15.99%.

Kings Global Biotech revenue growth over time
Kings Global Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 38.73%
*******
*******
*******
*******
Revenue from Operations
*******
 39.11%
*******
*******
*******
*******
Total Assets
*******
 143.71%
*******
*******
*******
*******
Profit or Loss
*******
 10.09%
*******
*******
*******
*******
Net Worth
*******
 15.99%
*******
*******
*******
*******
EBITDA
*******
 24.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kings Global Biotech?

In 2022, Kings Global Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹145,341,805.25

Satisfied Charges

₹48,063,397.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 14.32 Cr
  • The South Indian Bank Limited : 0.21 Cr
Latest Charge Details
Date Lender Amount Status
02 Apr 2025 The South Indian Bank Limited ₹0.90 M Open
12 Dec 2024 The South Indian Bank Limited ₹1.20 M Open
25 Mar 2021 Yes Bank Limited ₹14.32 Cr Open
26 Mar 2019 The South Indian Bank Limited ₹4.81 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Kings Global Biotech?

Unlock and access historical data on people associated with Kings Global Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kings Global Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kings Global Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kings Global Biotech
Recent Activity within the Organization
  • Charges

    A charge with The South Indian Bank Limited amounted to Rs. 0.09 Cr with Charge ID 101084677 was registered on 02 Apr 2025. was recorded as a recent event.

  • Charges

    A charge with The South Indian Bank Limited amounted to Rs. 0.12 Cr with Charge ID 101022510 was registered on 12 Dec 2024. was recorded as a recent event.

  • Annual General Meeting

    Kings Global Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Kings Global Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.

  • Director Appointment

    Kartiki Ramesh Tupe was appointed as a Additional Director was appointed as a Additional Director on 28 Sep 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Charges

    A charge registered on 26 Mar 2019 via Charge ID 100254389 with The South Indian Bank Limited was fully satisfied on 04 Jan 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kings Global Biotech Limited?

The CIN of Kings Global Biotech Limited is U33119PN2016PLC164905.

Where is Kings Global Biotech Limited headquartered?

Kings Global Biotech Limited is headquartered at Mittal Chambers, J.M.Road, Shivajinagar, Pune, Maharashtra, 411030.

When was Kings Global Biotech Limited incorporated?

Kings Global Biotech Limited was incorporated on 09 June 2016.

Who are the current directors of Kings Global Biotech Limited?

The current directors of Kings Global Biotech Limited are

What is the primary industry of Kings Global Biotech Limited?

The primary industry of Kings Global Biotech Limited is Trade.

Is Kings Global Biotech Limited a listed company?

Kings Global Biotech Limited is unlisted.

What is the capital structure of Kings Global Biotech Limited?

The authorized capital of Kings Global Biotech Limited is ₹2.00 Cr, and the paid-up capital is ₹1.81 Cr.

What is the compliance status of Kings Global Biotech Limited?

The compliance status of Kings Global Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available